345 related articles for article (PubMed ID: 18946424)
1. Anti-carcinogenic effects of the flavonoid luteolin.
Seelinger G; Merfort I; Wölfle U; Schempp CM
Molecules; 2008 Oct; 13(10):2628-2651. PubMed ID: 18946424
[TBL] [Abstract][Full Text] [Related]
2. Luteolin, a flavonoid, as an anticancer agent: A review.
Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Orhan IE; Rizwan M; Atif M; Gondal TA; Mubarak MS
Biomed Pharmacother; 2019 Apr; 112():108612. PubMed ID: 30798142
[TBL] [Abstract][Full Text] [Related]
3. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
4. Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells.
Chen D; Chen MS; Cui QC; Yang H; Dou QP
Front Biosci; 2007 Jan; 12():1935-45. PubMed ID: 17127432
[TBL] [Abstract][Full Text] [Related]
5. Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells.
Wang LM; Xie KP; Huo HN; Shang F; Zou W; Xie MJ
Asian Pac J Cancer Prev; 2012; 13(4):1431-7. PubMed ID: 22799344
[TBL] [Abstract][Full Text] [Related]
6. Role of microRNAs in the anticancer effects of the flavonoid luteolin: a systematic review.
Mishan MA; Khazeei Tabari MA; Mahrooz A; Bagheri A
Eur J Cancer Prev; 2021 Sep; 30(5):413-421. PubMed ID: 33720053
[TBL] [Abstract][Full Text] [Related]
7. Multi-Faceted Role of Luteolin in Cancer Metastasis: EMT, Angiogenesis, ECM Degradation and Apoptosis.
Rocchetti MT; Bellanti F; Zadorozhna M; Fiocco D; Mangieri D
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240168
[TBL] [Abstract][Full Text] [Related]
8. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin.
Seelinger G; Merfort I; Schempp CM
Planta Med; 2008 Nov; 74(14):1667-77. PubMed ID: 18937165
[TBL] [Abstract][Full Text] [Related]
9. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.
Brusselmans K; Vrolix R; Verhoeven G; Swinnen JV
J Biol Chem; 2005 Feb; 280(7):5636-45. PubMed ID: 15533929
[TBL] [Abstract][Full Text] [Related]
10. Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules.
Almatroodi SA; Almatroudi A; Alharbi HOA; Khan AA; Rahmani AH
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474604
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
Chakrabarti M; Ray SK
Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
[TBL] [Abstract][Full Text] [Related]
12. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
Benavente-García O; Castillo J
J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion.
Tavsan Z; Kayali HA
Biomed Pharmacother; 2019 Aug; 116():109004. PubMed ID: 31128404
[TBL] [Abstract][Full Text] [Related]
14. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY
J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells.
George VC; Naveen Kumar DR; Suresh PK; Kumar S; Kumar RA
Asian Pac J Cancer Prev; 2013; 14(2):631-7. PubMed ID: 23621210
[TBL] [Abstract][Full Text] [Related]
16. Distribution and biological activities of the flavonoid luteolin.
López-Lázaro M
Mini Rev Med Chem; 2009 Jan; 9(1):31-59. PubMed ID: 19149659
[TBL] [Abstract][Full Text] [Related]
17. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
18. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
Choi JS; Islam MN; Ali MY; Kim YM; Park HJ; Sohn HS; Jung HA
Arch Pharm Res; 2014 Oct; 37(10):1354-63. PubMed ID: 24988985
[TBL] [Abstract][Full Text] [Related]
19. Regulation of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of apigenin and luteolin as acting compounds.
Kim DI; Lee TK; Lim IS; Kim H; Lee YC; Kim CH
Toxicol Appl Pharmacol; 2005 Jun; 205(3):213-24. PubMed ID: 15922007
[TBL] [Abstract][Full Text] [Related]
20. Flavonoids, Breast Cancer Chemopreventive and/or Chemotherapeutic Agents.
Magne Nde CB; Zingue S; Winter E; Creczynski-Pasa TB; Michel T; Fernandez X; Njamen D; Clyne C
Curr Med Chem; 2015; 22(30):3434-46. PubMed ID: 26502949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]